lunes, 11 de febrero de 2019

Routine genetic testing for thoracic aortic disease may levy high costs to patients with little benefit. - PubMed - NCBI

Routine genetic testing for thoracic aortic disease may levy high costs to patients with little benefit. - PubMed - NCBI



 2019 Jan 29:2047487319825917. doi: 10.1177/2047487319825917. [Epub ahead of print]

Routine genetic testing for thoracic aortic disease may levy high costs to patients with little benefit.


PMID:
 
30696263
 
DOI:
 
10.1177/2047487319825917

No hay comentarios:

Publicar un comentario